Advertisement
open access
Medical Conferences
Conference Reports
Conference Proceedings
Disease Areas
Medical News
Multimedia
Podcast Channel
Videos
Webinar
About
2024 Medicom Conference Planning
Conference Proceedings
Home
>
Rheumatology
>
ACR 2022
ACR 2022
American College of Rheumatology
10–14 November 2022 Philadelphia, USA
Table of Contents
Colophon
Table of Contents
Featured articles
Bruton’s tyrosine kinase inhibition: a novel treatment option for Sjögren’s syndrome?
Presented By
Prof. Thomas Dörner, Charité University Hospital, Germany
Early treatment: a key to improved outcomes in polyarticular JIA
Presented By
Prof. Yukiko Kimura, Hackensack Meridian School of Medicine, USA
ACR 2022 Congress Round-Up
Glucocorticoids in rheumatic diseases: Is there a skeletal sparing dose?
Presented By
Dr Giovanni Adami, University of Verona, Italy
Bimekizumab: Robust 1-year results in treating psoriatic arthritis
Presented By
Prof. Christopher Ritchlin, University of Rochester Medical Center, USA
Stimulation of PD-1: a new concept to treat RA
Presented By
Prof. Paul Emery, University of Leeds, UK
Denosumab in erosive hand arthritis: Structure repair of interphalangeal joints seems possible
Presented By
Prof. Ruth Wittoek, Ghent University Hospital, Belgium
High retention rates after switching between infliximab biosimilars
Presented By
Dr Hafsah Nabi, Rigshospitalet, Denmar
New analysis assesses the safety of tofacitinib regarding extended MACE
Presented By
Prof. Maya Buch, University of Manchester, United Kingdom
Lack of vaccination results in a higher frequency of pre-term births in pregnant women with rheumatic disease and COVID-19
Presented By
Dr Sinead Magui, St. James’ Hospital, Ireland
Ankylosing spondylitis: Combining biologics with NSAID does not imply reduced radiographic progression
Presented By
Dr Fabian Proft, Charité University Hospital, Germany
Diet and exercise programme: a successful OA strategy in a community-based setting
Presented By
Prof. Stephen Messier, Wake Forest University, USA
Bruton’s tyrosine kinase inhibition: a novel treatment option for Sjögren’s syndrome?
Presented By
Prof. Thomas Dörner, Charité University Hospital, Germany
A novel risk score helps identify interstitial lung disease in patients with systemic sclerosis
Presented By
Dr Cosimo Bruni, University of Zürich, Switzerla
Early treatment: a key to improved outcomes in polyarticular JIA
Presented By
Prof. Yukiko Kimura, Hackensack Meridian School of Medicine, USA
TYK2 inhibition shows potential as a treatment for SLE
Presented By
Dr Marilyn Pike, MedPharm Consulting, MA, USA
Belimumab efficacious in cutaneous lupus erythematosus
Presented By
Dr Daniel Montes, University of Wisconsin, WI, USA
No increased cancer risk in patients with rheumatic diseases and prior malignancy treated with novel therapies
Presented By
Dr Juan Molina Collada , Gregorio Marañón General University Hospital, Spain